Inside the research

Colgate-Palmolive Company

CL Research profile · latest available data

Price overview

$86.06

▲ +0.74 (+0.9%)

52w hi$97.97
52w lo$73.64
Vol3.54M
As of25 Sep 2026

The Verdict

Hold

Our score -0.21

Short-0.10
Medium-0.27
Long-0.33

computed 2026-09-27

Key fundamentals

Colgate-Palmolive Company

Consumer Defensive · Household & Personal Products

Market cap$68.60B
Enterprise value$75.34B
Trailing P/E33.88x
Forward P/E20.98x
EV / EBITDA15.12x
P / S (ttm)3.26x
Profit margin9.7%
Return on equity267.4%
Revenue growth+4.9%
Earnings growth-5.5%
Debt / equity1388.16

Layer Breakdown

LayerRawContribution
Fundamental+0.13
Sector-0.01
Technical-0.13
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

United States · www.colgatepalmolive.com

Risk Metrics

Beta vs SPX0.01
Corr SPX0.01
Annual vol21.7%
Annual ret-6.7%
Sharpe-0.31
Max DD-27.8%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$96.00
High / Low$105.00 / $80.00
Median$100.00
Analysts19
Strong Buy6
Buy7
Hold7
Sell0
Strong Sell0

Recent rating actions

2026-05-05Barclays→ Equal-Weight
2026-05-04UBS→ Buy
2026-05-04RBC Capital→ Outperform
2026-05-04JP Morgan→ Overweight
2026-04-23Morgan Stanley→ Overweight
2026-04-21Rothschild & Co→ Buy

Officers & Board

CEONoel Wallace since 2019
FounderWilliam Colgate current

Material Events

DateEvent8-K
2026-07-31Earnings Release, Exhibitsread
2026-05-13Shareholder Voteread
2026-05-01Earnings Release, Restructuring…read
2026-04-09Officer / Director Changeread
2026-03-17Other Material Event, Exhibitsread
2026-03-12Officer / Director Changeread
2026-01-30Earnings Release, Exhibitsread
2025-11-10Other Material Event, Exhibitsread
2025-10-31Earnings Release, Restructuring…read
2025-08-01Earnings Release, Restructuring…read
2025-05-29Officer / Director Changeread
2025-05-14Shareholder Voteread

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders10
Top-5 share91.3%
HHI3,645 (concentrated)

Top Holders

HolderValueShares
State Street Corp$4.31B47.02M
Fidelity / FMR LLC$823.57M8.98M
Norges Bank (Norway sovereign)$752.30M8.21M
Citadel Advisors$495.69M5.41M
Capital Research / Capital World$463.56M5.06M
AQR Capital Management$426.78M4.67M
Millennium Management$134.34M1.47M
Renaissance Technologies$80.86M881.93K
Bridgewater Associates$7.07M77.09K
T. Rowe Price Group$2.56M27.91M

As of 2026-06-30

Dividends

Yield (TTM)1.82%
$ / share (TTM)$1.57
5y CAGR+3.3%

Annual dividend per share

2021$1.79
2022$1.86
2023$1.91
2024$1.98
2025$2.06
2026$1.05

SEC Filings

DateFormDoc
2026-08-074view
2026-08-064view
2026-07-318-Kview
2026-07-3110-Qview
2026-07-024view
2026-07-024view
2026-07-024view
2026-06-2411-Kview
2026-06-2411-Kview
2026-06-174view
2026-06-053view
2026-05-184view
2026-05-134view
2026-05-134view
2026-05-134view

The Long Run

FY 2009–2025 · 17 years

LineLatestCAGRTrend
Revenue$20.10B+1.7%
Gross profit$11.33B+1.4%
Operating income$3.98B+0.6%
Net income$2.89B+2.5%
Cash from ops$3.75B+0.8%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$85.09$86.14$85.05$86.063.54M
Sep 24$86.33$87.25$85.29$85.324.78M
Sep 23$86.77$87.40$85.77$85.936.22M
Sep 22$87.09$87.55$86.86$87.057.59M
Sep 21$87.26$87.27$86.03$86.267.28M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →